Phase engineering of two-dimensional transition metal dichalcogenides (2D-TMDs) offers opportunities for exploring unique phase-specific properties and achieving new desired functionalities. Here, we report a phase-selective in-plane heteroepitaxial method to grow semiconducting H-phase CrSe. The lattice-matched MoSe nanoribbons are utilized as the in-plane heteroepitaxial template to seed the growth of H-phase CrSe with the formation of MoSe-CrSe heterostructures.
View Article and Find Full Text PDFMetal sulfides, one kind of electrode material with very high theoretical capacity, have been widely studied for use in lithium and sodium ion batteries. However, there are some problems hindering their applications in electrodes, such as low conductivity and volume expansion. The MOF introduces metals with different coordination strengths into an existing MOF structure, which improves the performance of the electrode to a certain extent.
View Article and Find Full Text PDFSensory adaptation is an essential function for humans to live on the earth. Herein, a hybrid synaptic phototransistor based on the mixed-halide perovskite/organic semiconductor film is reported. This hybrid phototransistor achieves photosensitive performance including a high photoresponsivity over 4 × 10 A/W and an excellent specific detectivity of 2.
View Article and Find Full Text PDFAn artificial synaptic device that can provide color discrimination, image storage, and image recognition is highly required to mimic the human vision for biological robots. All-inorganic halide perovskites have attracted extensive attention for the reason of their high stability and favorable photoelectric properties. In this study, a light-stimulated synaptic phototransistor based on a CsPbBr/organic semiconductor hybrid film is reported.
View Article and Find Full Text PDFZhonghua Xin Xue Guan Bing Za Zhi
June 2013
Objective: To observe the blood lowering effect of telmisartan and amlodipine taking on the morning or at bedtime in hypertensive patients.
Methods: A total of 108 individuals with hypertension (grade 2 or above) were randomized to receive telmisartan and amlodipine in one of the following four therapeutic schemes: Group A (26 cases): both medications taken on the morning; Group B (28 cases): both medication taken at bedtime; Group C (27 cases): telmisartan on the morning and amlodipine at bedtime; or Group D (27 cases): amlodipine on the morning and telmisartan at bedtime. ABPM was performed before and after 8 weeks treatment.